ALICE WATSON: Open Payments
NPI 1447001243 · HAMILTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,064 in 121 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,256 · 2025 $2,064
Food & beverage: $2,064
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 61 | $1,040 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $217 |
| Aimmune Therapeutics, Inc. | 13 | $198 |
| Madrigal Pharmaceuticals | 8 | $158 |
| GENZYME CORPORATION | 5 | $109 |
| Janssen Biotech, Inc. | 5 | $95 |
| Novo Nordisk Inc | 3 | $55 |
| Gilead Sciences, Inc. | 3 | $52 |
| EVOKE PHARMA, INC. | 2 | $48 |
| QOL Medical, LLC | 2 | $41 |
Products named: MAVYRET, SKYRIZI, RINVOQ, ENTYVIO, ZENPEP, REZDIFFRA, VIBERZI, LINZESS.
Industry payments across OH — which companies pay providers there.
